产品中心

PRODUCTS

Current location:Home >> 产品中心 >> 抗体

PRODUCT CLASSIFICATION

News

NEWS
Application of bioactive small molecules in disease research
Green intelligence creates industry trends, Fuzhen Biology promotes low-carbon development of fine chemical industry
The monoclonal antibody industry is developing rapidly, and Fuzhen Biotechnology is improving its supply system for monoclonal antibody related raw materials
The global biopharmaceutical market continues to expand
Molecular building blocks are used as accelerators for the development of new drugs
Structural formula
Art.No.
Name
CAS
Pureness
西妥木单抗
CFZ02265
Cixutumumab
947687-12-9
95%
乌珠单抗
CFZ02264
Urtoxazumab
502496-16-4
95%
伊斯利莫
CFZ02263
Elsilimomab
468715-71-1
95%
曲美木单抗
CFZ02262
Tremelimumab
745013-59-6
95%
芬妥木单抗
CFZ02261
Figitumumab
943453-46-1
95%
瑞利珠单抗
CFZ02260
reslizumab
241473-69-8
95%
依美昔单抗
CFZ02258
Ecromeximab
292819-64-8
95%
贝利木单抗
CFZ02257
Belimumab
356547-88-1
95%
伐利昔单抗
CFZ02256
Vapaliximab
336801-86-6
95%
西莫白介素单抗
CFZ02255
Tucotuzumab Celmoleukin
339986-90-2
95%
Service Hotline：
15111215862
18229892877